5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.64▼ | 6.70▼ | 6.75▼ | 7.25▼ | 7.42▼ |
MA10 | 6.76▼ | 6.86▼ | 7.02▼ | 7.55▼ | 8.52▼ |
MA20 | 6.90▼ | 7.10▼ | 7.25▼ | 7.75▼ | 9.24▼ |
MA50 | 7.20▼ | 7.48▼ | 7.68▼ | 8.92▼ | 6.52▼ |
MA100 | 7.51▼ | 7.76▼ | 7.87▼ | 9.01▼ | 6.16▲ |
MA200 | 7.78▼ | 8.36▼ | 8.71▼ | 6.76▼ | 6.81▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.033▼ | -0.054▼ | -0.076▼ | -0.066▼ | -0.516▼ |
RSI | 13.327▼ | 21.433▼ | 25.086▼ | 32.193▼ | 39.385▼ |
STOCH | 3.846▼ | 2.351▼ | 1.810▼ | 12.987▼ | 11.601▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -98.410▼ | -99.292▼ |
CCI | -199.791▼ | -155.038▼ | -173.891▼ | -237.842▼ | -139.977▼ |
Monday, April 28, 2025 06:45 AM
HACKENSACK, NJ / ACCESS Newswire / April 28, 2025 / Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in ...
|
Monday, April 28, 2025 06:05 AM
Champions Oncology (NASDAQ:CSBR), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work ...
|
Sunday, April 13, 2025 01:50 AM
Champions Oncology, Inc. (NASDAQ:CSBR) shareholders have seen the share price descend 23% over the month. But that doesn't change the reality that over twelve months the stock has done really well.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 7.20 | 7.4814 | 6.34 | 6.38 | 70,654 |
30/04/25 | 7.755 | 7.755 | 7.15 | 7.15 | 26,841 |
29/04/25 | 7.59 | 7.67 | 7.49 | 7.53 | 24,970 |
28/04/25 | 7.98 | 8.27 | 7.209 | 7.31 | 83,346 |
25/04/25 | 8.14 | 8.20 | 7.88 | 7.90 | 26,748 |
24/04/25 | 7.95 | 8.12 | 7.61 | 7.61 | 6,796 |
23/04/25 | 8.03 | 8.0952 | 7.70 | 7.87 | 17,311 |
22/04/25 | 7.98 | 8.1271 | 7.75 | 7.86 | 16,850 |
21/04/25 | 7.93 | 8.44 | 7.74 | 7.92 | 16,625 |
17/04/25 | 8.17 | 8.8564 | 7.935 | 7.97 | 25,876 |
|
|
||||
|
|
||||
|
|